Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Affymax receives $5M payment for drug development - The Associated Press PDF Print
The Associated PressThe US Phase 3 clinical program enrolled about 2600 chronic renal failure patients at approximately 400 clinical trial sites. Affymax shares fell 4 cents to ...Affymax(R) Receives $5 Million Milestone Payment on Initiation of Phase 3

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.